Cover Image
Market Research Report
Product code 
1107709

IDC Perspective: How Technology Is Driving Diversity and Equity in Clinical Trials

Published: | IDC | 12 Pages | Delivery time: 1-2 business days

Price

Back to Top
IDC Perspective: How Technology Is Driving Diversity and Equity in Clinical Trials
Published: July 25, 2022
IDC
Content info: 12 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

This IDC Perspective reviews the existing landscape and critical challenges associated with driving diversity and equity in clinical trials. It reviews strategies that pharma is using to address these challenges and scans the evolving technology landscape that is playing a critical role in driving change. It also examines regulatory policies and guidances, identifies the key measures of success, and provides guidance on implementing a diversity strategy."Inclusive clinical development is a must to address the deep-rooted disparities that prevail across the globe. There is no silver bullet to address this issue. It requires a focused, sustained, and collaborative effort; it requires sensitivity and empathy to be woven into technology and strategy; and it calls for a genuine deep-seated commitment toward driving inclusiveness and equity in clinical trials," says Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy and Technology at IDC Health Insights.

Product Code: US47817922

Executive Snapshot

Situation Overview

  • The Current Scenario
  • Where Do the Challenges Lie?
  • Evolving Regulations That Are Impacting D&I in Clinical Trials
    • Integrating Diversity into Approval Decisions for Oncology Studies
  • Strategies Leveraged by Pharma to Increase Diversity in Clinical Trials
  • Key Players Providing D&I Solutions
  • Identifying Measures of Success

Advice for the Technology Buyer

Learn More

  • Related Research
  • Synopsis